377 related articles for article (PubMed ID: 15794670)
1. Regulators of apoptosis in cholangiocarcinoma.
Jhala NC; Vickers SM; Argani P; McDonald JM
Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
[TBL] [Abstract][Full Text] [Related]
2. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
3. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
4. Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes.
Hughes NR; Pairojkul C; Royce SG; Clouston A; Bhathal PS
J Clin Pathol; 2006 Oct; 59(10):1073-8. PubMed ID: 16679351
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas.
Teh M; Wee A; Raju GC
Cancer; 1994 Sep; 74(5):1542-5. PubMed ID: 7520348
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas.
Karamitopoulou E; Tornillo L; Zlobec I; Cioccari L; Carafa V; Borner M; Schaffner T; Brunner T; Diamantis I; Zimmermann A; Terracciano L
Am J Clin Pathol; 2008 Nov; 130(5):780-6. PubMed ID: 18854271
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.
Chuang SC; Lee KT; Tsai KB; Sheen PC; Nagai E; Mizumoto K; Tanaka M
World J Surg; 2004 Oct; 28(10):995-1000. PubMed ID: 15573254
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts.
Washington K; Gottfried MR
Liver; 1996 Apr; 16(2):99-104. PubMed ID: 8740842
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
[TBL] [Abstract][Full Text] [Related]
12. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
13. p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis.
Rizzi PM; Ryder SD; Portmann B; Ramage JK; Naoumov NV; Williams R
Gut; 1996 Feb; 38(2):265-8. PubMed ID: 8801209
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.
Lee CT; Wu TT; Lohse CM; Zhang L
Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603
[TBL] [Abstract][Full Text] [Related]
15. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver.
Shimonishi T; Zen Y; Chen TC; Chen MF; Jan YY; Yeh TS; Nimura Y; Nakanuma Y
Hum Pathol; 2002 May; 33(5):503-11. PubMed ID: 12094375
[TBL] [Abstract][Full Text] [Related]
16. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
[TBL] [Abstract][Full Text] [Related]
17. [Gallbladder and bile duct carcinoma. Biology and pathology].
Tannapfel A; Wittekind C
Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
[TBL] [Abstract][Full Text] [Related]
18. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
[TBL] [Abstract][Full Text] [Related]
19. Autophagy may occur at an early stage of cholangiocarcinogenesis via biliary intraepithelial neoplasia.
Sasaki M; Nitta T; Sato Y; Nakanuma Y
Hum Pathol; 2015 Feb; 46(2):202-9. PubMed ID: 25466963
[TBL] [Abstract][Full Text] [Related]
20. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]